Novo Nordisk A/S
NVO
$65.77
$0.921.42%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -10.05% | 16.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.05% | 16.53% | |||
| Cost of Revenue | 5.48% | 3.45% | |||
| Gross Profit | -12.59% | 19.00% | |||
| SG&A Expenses | -21.55% | 18.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 98.13% | -810.58% | |||
| Total Operating Expenses | -10.02% | 11.52% | |||
| Operating Income | -10.07% | 22.09% | |||
| Income Before Tax | 2.80% | 0.29% | |||
| Income Tax Expenses | 7.76% | 0.33% | |||
| Earnings from Continuing Operations | 1.52% | 0.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.52% | 0.28% | |||
| EBIT | -10.07% | 22.09% | |||
| EBITDA | -4.99% | 19.37% | |||
| EPS Basic | 1.66% | 0.42% | |||
| Normalized Basic EPS | -11.61% | 16.97% | |||
| EPS Diluted | 1.69% | 0.44% | |||
| Normalized Diluted EPS | -11.55% | 16.95% | |||
| Average Basic Shares Outstanding | -0.15% | -0.14% | |||
| Average Diluted Shares Outstanding | -0.20% | -0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -1.00% | |||